US 8921071
Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections
granted A61KA61K2039/6037A61K2039/6056
Quick answer
US patent 8921071 (Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/6037, A61K2039/6056, A61K2039/6081, A61K39/085